172 related articles for article (PubMed ID: 32859632)
21. [Correlation of expression of RhoC with invasiveness of prostate cancer cell line PC-3M in vitro].
Yuan Z; Su J; You JF; Wang JL; Cui XL; Zheng J
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):51-5. PubMed ID: 18346381
[TBL] [Abstract][Full Text] [Related]
22. Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth.
Ruscica M; Magni P; Steffani L; Gatto F; Albertelli M; Rametta R; Valenti L; Ameri P; Magnaghi V; Culler MD; Minuto F; Ferone D; Arvigo M
Mol Cell Endocrinol; 2014 Feb; 382(2):860-70. PubMed ID: 24211300
[TBL] [Abstract][Full Text] [Related]
23. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
Yu WJ; Wang YW; Xie ZG; You JF; Wang JL; Cui XL; Pei F; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):88-94. PubMed ID: 20388373
[TBL] [Abstract][Full Text] [Related]
24. Quantitative proteomic study of human prostate cancer cells with different metastatic potentials.
Li Q; Li Y; Wang Y; Cui Z; Gong L; Qu Z; Zhong Y; Zhou J; Zhou Y; Gao Y; Li Y
Int J Oncol; 2016 Apr; 48(4):1437-46. PubMed ID: 26846621
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation.
Wei J; Xu G; Wu M; Zhang Y; Li Q; Liu P; Zhu T; Song A; Zhao L; Han Z; Chen G; Wang S; Meng L; Zhou J; Lu Y; Wang S; Ma D
Anticancer Res; 2008; 28(1A):327-34. PubMed ID: 18383865
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway.
Senapati S; Rachagani S; Chaudhary K; Johansson SL; Singh RK; Batra SK
Oncogene; 2010 Mar; 29(9):1293-302. PubMed ID: 19946339
[TBL] [Abstract][Full Text] [Related]
27. Small interference RNA-mediated silencing of prostate stem cell antigen attenuates growth, reduces migration and invasion of human prostate cancer PC-3M cells.
Zhao Z; Ma W; Zeng G; Qi D; Ou L; Liang Y
Urol Oncol; 2013 Apr; 31(3):343-51. PubMed ID: 21429770
[TBL] [Abstract][Full Text] [Related]
28. Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer.
Wu W; Yang Q; Fung KM; Humphreys MR; Brame LS; Cao A; Fang YT; Shih PT; Kropp BP; Lin HK
Mol Cell Endocrinol; 2014 Mar; 383(1-2):69-79. PubMed ID: 24296312
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
[TBL] [Abstract][Full Text] [Related]
30. Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells.
Sahu SN; Nunez S; Bai G; Gupta A
Am J Physiol Cell Physiol; 2007 Jun; 292(6):C2288-96. PubMed ID: 17329398
[TBL] [Abstract][Full Text] [Related]
31. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
32. Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.
Bisoffi M; Klima I; Gresko E; Durfee PN; Hines WC; Griffith JK; Studer UE; Thalmann GN
J Urol; 2004 Sep; 172(3):1145-50. PubMed ID: 15311059
[TBL] [Abstract][Full Text] [Related]
33. Immune profiling of human prostate epithelial cells determined by expression of p38/TRAF-6/ERK MAP kinases pathways.
Bouraoui Y; Achour M; Royuela M; Oueslati R
Kaohsiung J Med Sci; 2018 Mar; 34(3):125-133. PubMed ID: 29475459
[TBL] [Abstract][Full Text] [Related]
34. Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
Kurozumi A; Goto Y; Matsushita R; Fukumoto I; Kato M; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
Cancer Sci; 2016 Jan; 107(1):84-94. PubMed ID: 26509963
[TBL] [Abstract][Full Text] [Related]
35. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.
Chung S; Furihata M; Tamura K; Uemura M; Daigo Y; Nasu Y; Miki T; Shuin T; Fujioka T; Nakamura Y; Nakagawa H
Oncogene; 2009 Aug; 28(32):2849-59. PubMed ID: 19483721
[TBL] [Abstract][Full Text] [Related]
36. miR-20a promotes prostate cancer invasion and migration through targeting ABL2.
Qiang XF; Zhang ZW; Liu Q; Sun N; Pan LL; Shen J; Li T; Yun C; Li H; Shi LH
J Cell Biochem; 2014 Jul; 115(7):1269-76. PubMed ID: 24464651
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanism of adaphostin-mediated G1 arrest in prostate cancer (PC-3) cells: signaling events mediated by hepatocyte growth factor receptor, c-Met, and p38 MAPK pathways.
Mukhopadhyay I; Sausville EA; Doroshow JH; Roy KK
J Biol Chem; 2006 Dec; 281(49):37330-44. PubMed ID: 16956884
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide gene expression analysis of a murine model of prostate cancer progression: Deciphering the roles of IL-6 and p38 MAPK as potential therapeutic targets.
Daouk R; Bahmad HF; Saleh E; Monzer A; Ballout F; Kadara H; Abou-Kheir W
PLoS One; 2020; 15(8):e0237442. PubMed ID: 32790767
[TBL] [Abstract][Full Text] [Related]
39. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z
Life Sci; 2020 May; 248():117449. PubMed ID: 32088212
[TBL] [Abstract][Full Text] [Related]
40. EphA3, induced by PC-1/PrLZ, contributes to the malignant progression of prostate cancer.
Wu R; Wang H; Wang J; Wang P; Huang F; Xie B; Zhao Y; Li S; Zhou J
Oncol Rep; 2014 Dec; 32(6):2657-65. PubMed ID: 25231727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
